October 21, 2014 11:34 PM ET

Pharmaceuticals

Company Overview of Blueprint Medicines Corp.

Executive Profile

George D. Demetri M.D.

Clinical Advisor and Member of Scientific Advisory Board, Blueprint Medicines Corp.
AgeTotal Calculated CompensationThis person is connected to 9 Board Members in 9 different organizations across 14 different industries.

See Board Relationships
----

Background

Dr. George D. Demetri, M.D. has been Clinical Advisor of Blueprint Medicines Corp. since May 2012. Dr. Demetri is the Founder and Editor of Sarcoma.net. Dr. Demetri serves as a Scientific Advisor of TransTech Pharma Inc. Dr. Demetri serves as a Scientific Advisor of Champions Oncology, Inc. Dr. Demetri serves as Director of the Center for Sarcoma and Bone Oncology in the Department of Medical Oncology at the Dana-Farber Cancer Institute and Brighasm and Women's Hospital, ...

Corporate Headquarters

215 First Street
Cambridge, Massachusetts 02142

United States

Phone: 617-374-7580
Fax: --

Board Members Memberships

Former Director

Education

Bachelor's Degree
Harvard University
MD 1983
Stanford University School of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Blueprint Medicines Corp., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.